Baker McKenzie advised Global New Material International Ltd. on the deal. Global New Material International Ltd. (“GNMI”) signed an agreement with Merck KGaA (“Merck”) to acquire...
Global New Material International’s Agreement with Merck KGaA
CureVac’s Collaboration with GSK
Baker McKenzie advised CureVac on the deal. CureVac N.V., a global biopharmaceutical company developing transformative medicines based on messenger ribonucleic acid (mRNA), restructured its existing collaboration...